24/7 Patient Assistance: 760-405-8205

John Jakob, MD PhD

Medical Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Laryngeal Cancer Lung Cancer Ovarian Cancer Pericardial Mesothelioma Peritoneal Mesothelioma Pleural Mesothelioma Testicular Mesothelioma

Hospitals & Clinics

  • Bio & Insurance Information
  • Education & Training


    Columbia University College of Physicians & Surgeons

    Medical School


    Case Western Reserve University - University Hospitals



    University of Texas MD Anderson Cancer Center


  • Board Certifications

    American Board of Internal Medicine - Oncology

  • Hospital & Practice

    Mercy Medical Center Canton

    Languages: English/Spanish

    +1 330-489-1000

    1320 Mercy Drive Northwest

    Canton, OH 44708

    Read More
  • Publications & Memberships

    Dr. John Jakob has contributed to 3 publications.

    A Phase II study of Gefitinib in Patients with Advanced Salivary Gland Cancers.

    Jakob JA Kies MS Glisson BS Kupferman ME Liu DD Lee JJ El-Naggar AK Gonzalez-Angulo AM Blumenschein GR; Head Neck. 2014 Mar 2 .

    See more >>

    Clinical characteristics and outcomes with specific BRAF and NRAS mutations in patients with metastatic melanoma.

    Bucheit, A. D.,Syklawer, E.,Jakob, J. A.,Bassett, R. L.,Curry, J. L.,Gershenwald, J. E.,Kim, K. B.,Hwu, P.,Lazar, A. J.,Davies, M. A.; Cancer. 2013 Aug 6.

    See more >>

    Characterizing the clinical benefit of ipilimumab in patients who progressed on high-dose IL-2.

    Joseph RW Eckel-Passow JE Sharma R Liu P Parker A Jakob J Buchbinder E Bassett RL Davies MA Hwu P Atkins MB Sullivan RJ; J Immunother. 2012 Nov-Dec .

    See more >>